FSH: What This Test Actually Measures

What FSH Is and Where It Comes From

FSH is a glycoprotein hormone secreted by gonadotroph cells in the anterior pituitary gland. It consists of two subunits: an alpha subunit shared with LH, TSH, and hCG, and a unique beta subunit that gives FSH its biological specificity [1]. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses, and each pulse triggers a burst of FSH (and LH) from the pituitary.

In women, FSH binds to receptors on ovarian granulosa cells, stimulating follicle growth and estradiol production during the first half of the menstrual cycle. The 2020 Endocrine Society Clinical Practice Guideline on female infertility describes FSH as "the principal hormonal driver of follicular recruitment and maturation" [2]. In men, FSH acts on Sertoli cells within the seminiferous tubules to support spermatogenesis [3]. Without adequate FSH signaling, sperm production drops and follicular development stalls.

A negative feedback loop governs FSH secretion. Rising estradiol and inhibin B from the developing follicle (or Sertoli cells in men) signal the pituitary to reduce FSH output. When ovarian reserve declines, as it does approaching menopause, estradiol and inhibin B fall. The pituitary responds by producing more FSH. That mechanism is why elevated FSH serves as a biomarker for diminished ovarian reserve and menopausal transition [4].

How the FSH Blood Test Works

A standard FSH test requires a venous blood draw, typically from the antecubital vein. No fasting is necessary. The sample is processed by immunoassay, most commonly a chemiluminescent or electrochemiluminescent method, and results are reported in milli-international units per milliliter (mIU/mL).

Timing matters. In premenopausal women, FSH should be drawn on cycle day 2, 3, or 4 of the menstrual cycle, during the early follicular phase, because that is when baseline ovarian feedback is most interpretable [5]. Drawing FSH at mid-cycle will capture the LH/FSH surge and produce a misleadingly high number. The American Society for Reproductive Medicine (ASRM) recommends pairing day-3 FSH with a serum estradiol level to confirm the result is not falsely suppressed by elevated estradiol [6].

For men, a single morning sample is usually sufficient. FSH levels in men do not fluctuate with a monthly cycle, though diurnal variation is modest. The Endocrine Society's 2018 guideline on male hypogonadism recommends measuring FSH alongside LH and total testosterone when evaluating spermatogenic failure [7].

Results typically return within one to two business days. Point-of-care FSH tests exist (such as urine-based menopause self-test kits), but the American College of Obstetricians and Gynecologists (ACOG) has cautioned that "a single FSH measurement, whether serum or urinary, cannot reliably confirm or exclude menopausal status" because of the hormone's inter-cycle variability during the menopausal transition [8].

Normal FSH Ranges by Age and Sex

FSH reference ranges vary by laboratory, assay platform, and clinical context. The values below reflect consensus ranges cited by major reference laboratories and the Endocrine Society [1][7].

Females (premenopausal)

• Follicular phase: 3.5 to 12.5 mIU/mL
• Mid-cycle peak: 4.7 to 21.5 mIU/mL
• Luteal phase: 1.7 to 7.7 mIU/mL

Females (postmenopausal)

• 25.8 to 134.8 mIU/mL

Males (adult)

• 1.5 to 12.4 mIU/mL

Children (prepubertal)

• <0.2 to 4.0 mIU/mL in both sexes

A day-3 FSH above 10 mIU/mL in a premenopausal woman raises concern for diminished ovarian reserve. In a large retrospective analysis of 5,354 IVF cycles at a single center, Scott et al. found that day-3 FSH levels above 15 mIU/mL were associated with significantly lower pregnancy rates per cycle (odds ratio 0.36 to 95% CI 0.22 to 0.58) compared to levels below 10 mIU/mL [9]. That finding, while limited by its single-center design, has been replicated across multiple fertility cohorts and remains a clinical benchmark.

Context is everything. A 42-year-old woman with a day-3 FSH of 11 mIU/mL and an anti-Mullerian hormone (AMH) of 0.4 ng/mL has a different prognosis than a 30-year-old with identical FSH and an AMH of 3.2 ng/mL. FSH alone does not dictate ovarian reserve; it is one signal in a panel.

What High FSH Results Mean

Elevated FSH points to the gonads, not the pituitary. The pituitary is working harder because the ovaries or testes are responding less.

In women, persistently elevated FSH (above 25 mIU/mL on two separate measurements taken at least one month apart) is one of the laboratory criteria the Endocrine Society uses to confirm menopause [4]. During perimenopause, FSH can swing between normal and elevated from month to month, which is why a single high reading is insufficient for diagnosis. The 2015 NICE guideline on menopause diagnosis notes that FSH testing "is not required in women over 45 with typical menopausal symptoms" but is helpful in women aged 40 to 45 with menopause-like symptoms or women under 40 when premature ovarian insufficiency (POI) is suspected [10].

In women under 40, two FSH values above 25 mIU/mL measured four weeks apart, combined with menstrual irregularity and estradiol below 50 pg/mL, support a diagnosis of POI [11]. POI affects roughly 1% of women under age 40 and 0.1% under age 30 [11].

In men, elevated FSH with low testosterone and small testicular volume suggests primary testicular failure. Klinefelter syndrome (47,XXY), the most common genetic cause of male hypogonadism, presents with FSH levels often exceeding 20 mIU/mL [7]. Dr. Shalender Bhasin, co-author of the Endocrine Society's male hypogonadism guideline, has stated: "An elevated FSH with a low sperm count localizes the defect to the testis and distinguishes primary from secondary hypogonadism in a single step" [7].

Other causes of high FSH include gonadal damage from chemotherapy, radiation, surgical removal of ovaries or testes, and autoimmune gonadal failure. Chronic heavy alcohol use can also impair gonadal function and raise FSH over time [3].

What Low FSH Results Mean

Low FSH signals a problem upstream, at the hypothalamus or pituitary.

Hypogonadotropic hypogonadism, the clinical term for insufficient gonadotropin secretion, produces low FSH alongside low LH and low sex steroids. Causes include pituitary tumors (most commonly prolactinomas), head trauma, infiltrative diseases like hemochromatosis, and congenital conditions such as Kallmann syndrome [12]. Kallmann syndrome affects approximately 1 in 30,000 males and 1 in 125,000 females and pairs GnRH deficiency with anosmia [12].

Functional hypothalamic amenorrhea (FHA) is another common cause of low FSH in premenopausal women. Excessive exercise, caloric restriction, or psychological stress can suppress GnRH pulsatility, which in turn reduces FSH and LH output [13]. The Endocrine Society's 2017 guideline on FHA describes it as "a diagnosis of exclusion" and emphasizes that FSH is typically in the low-normal range (2 to 5 mIU/mL) rather than undetectable [13].

Medications can suppress FSH as well. Combined oral contraceptives, GnRH agonists (like leuprolide), GnRH antagonists (like cetrorelix), and exogenous testosterone all lower FSH through negative feedback. In men on testosterone replacement therapy, FSH suppression is expected and essentially universal, which is why exogenous testosterone functions as a male contraceptive at sufficient doses [14]. The 2018 Endocrine Society guideline on male hypogonadism specifically warns that "testosterone therapy suppresses spermatogenesis and should not be used as a fertility treatment" [7].

FSH in Fertility Workups

Day-3 FSH paired with estradiol is one of the oldest ovarian reserve markers in reproductive endocrinology. It remains part of the initial fertility workup recommended by ASRM, though AMH and antral follicle count (AFC) have become co-equal or preferred markers in many clinics [6].

The clinical value of day-3 FSH is its specificity. A consistently elevated day-3 FSH (above 10 mIU/mL in most labs) predicts poor ovarian response to gonadotropin stimulation during IVF. In a meta-analysis of 21 studies published in Fertility and Sterility, Broekmans et al. reported that basal FSH had a pooled positive likelihood ratio of 3.3 for predicting poor ovarian response, though sensitivity was modest at 47% [15]. AMH performs better on sensitivity, which is why modern protocols use both markers.

One nuance worth noting: a normal day-3 FSH does not guarantee adequate ovarian reserve. The "FSH flare" phenomenon, where a previously elevated FSH normalizes in a given cycle due to a dominant follicle producing enough estradiol, can mask declining reserve. ASRM recommends interpreting "the highest-ever recorded FSH value as the most clinically significant" rather than averaging multiple results [6].

For men with infertility, FSH helps distinguish obstructive from non-obstructive azoospermia. Normal FSH with azoospermia suggests obstruction. Elevated FSH with azoospermia points to spermatogenic failure. This distinction guides whether a urologist pursues surgical sperm retrieval versus vassal reconstruction [7].

How to Interpret FSH Alongside Other Hormones

FSH in isolation has limited clinical meaning. Three pairings matter most.

FSH and LH together. The FSH-to-LH ratio provides diagnostic information. In polycystic ovary syndrome (PCOS), LH is often elevated while FSH remains normal or low, producing an LH:FSH ratio above 2:1 in some patients, though the 2023 international evidence-based PCOS guideline notes this ratio "should not be used as a diagnostic criterion" because it lacks sufficient sensitivity [16]. In central hypogonadism, both FSH and LH are low. In primary gonadal failure, both are high.

FSH and estradiol. A day-3 estradiol above 60 to 80 pg/mL can suppress FSH into a falsely reassuring range. If the pituitary sees enough estradiol, it dials back FSH production even when ovarian reserve is declining. That is why a "normal" day-3 FSH paired with a high day-3 estradiol is not actually reassuring [6].

FSH and testosterone (in men). High FSH with low testosterone confirms primary hypogonadism. Low FSH with low testosterone confirms secondary hypogonadism. Normal FSH with normal testosterone but low sperm count suggests isolated spermatogenic defects or partial obstruction [7].

Practical Considerations: Can You Change Your FSH Level?

Because FSH is a pituitary response to gonadal feedback, the clinical goal is rarely to change FSH directly. Instead, the strategy targets whatever is driving FSH up or down.

For women with high FSH due to diminished ovarian reserve, no intervention reliably lowers FSH in a way that restores fertility. DHEA supplementation (25 mg three times daily) has been studied as a pre-treatment before IVF. A randomized controlled trial by Narkwichian et al. (N=52) showed modest improvement in oocyte yield but did not significantly change FSH levels [17]. The evidence base remains small and conflicting.

For women with low FSH due to hypothalamic amenorrhea, restoring energy balance through adequate nutrition and reduced exercise intensity is the first-line approach. The Endocrine Society guideline recommends cognitive behavioral therapy as an adjunct and cautions against using oral contraceptives as a substitute, since they mask the underlying hypothalamic dysfunction without treating it [13].

For men with low FSH due to exogenous testosterone use, discontinuing testosterone and, if fertility is desired, initiating clomiphene citrate (25 to 50 mg daily) or human chorionic gonadotropin (hCG) can restore FSH secretion and spermatogenesis over 3 to 6 months in most cases [7]. The Endocrine Society recommends hCG with or without recombinant FSH for men with secondary hypogonadism who want to preserve or restore fertility.

For men with high FSH due to primary testicular failure, FSH elevation is a consequence, not a target. Treatment focuses on testosterone replacement for symptom management and, when possible, testicular sperm extraction for fertility preservation [7].

When to Retest and How Often to Monitor

A single FSH measurement can be misleading. Pulsatile GnRH secretion means FSH fluctuates, sometimes by 20 to 30% within hours. Across the menopausal transition, cycle-to-cycle FSH variation can exceed 50% [4].

Retesting guidelines depend on clinical context. For perimenopause evaluation, repeat FSH in 4 to 6 weeks, drawing again in the early follicular phase if cycles are still present [4]. For suspected POI, confirm with a second FSH measurement at least 4 weeks after the first [11]. For male infertility, a single morning FSH paired with semen analysis is usually sufficient for initial classification, though the Endocrine Society suggests repeating abnormal results once before making treatment decisions [7].

Patients on hormone therapy generally do not need routine FSH monitoring. The exception is women on menopausal hormone therapy who want to know if they can stop: FSH measured after a washout period (at least 2 weeks off therapy) above 30 mIU/mL, combined with age over 50, strongly suggests that natural menopause has occurred [4]. For men on clomiphene or hCG for fertility restoration, FSH should be checked at 3-month intervals alongside semen analysis until sperm counts recover to target levels of at least 5 to 10 million per mL [7].